OSUR / OraSure said its rapid COVID-19 tests can now be used in children

OraSure Technologies (OSUR) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to more_horizontal

Today, we take our first look at OraSure Technologies, Inc., which has seen a huge and recent surge of revenues. However, this was almost entirely due more_horizontal

OraSure Technologies, Inc. (NASDAQ:OSUR ) Q1 2023 Earnings Conference Call May 10, 2023 5:00 PM ET Company Participants Scott Gleason - Head of Invest more_horizontal

OraSure Technologies (OSUR) came out with quarterly earnings of $0.37 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compare more_horizontal

BETHLEHEM, Pa., May 03, 2023 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering more_horizontal

Here is how OraSure Technologies (OSUR) and Acadia Pharmaceuticals (ACAD) have performed compared to their sector so far this year. more_horizontal

OraSure (OSUR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the s more_horizontal

OraSure has robust growth throughout the P&L, cash flows and balance sheet. Core business exhibiting remarkable upsides without Covid-19 revenues. more_horizontal